TY - JOUR
T1 - Clinical Evaluation of an Individualized Risk Prediction Tool for Men on Active Surveillance for Prostate Cancer
AU - Huntley, Joseph H.
AU - Coley, Rebecca Y.
AU - Carter, H. Ballentine
AU - Radhakrishnan, Archana
AU - Krakow, Melinda
AU - Pollack, Craig E.
N1 - Publisher Copyright:
© 2018
PY - 2018/11
Y1 - 2018/11
N2 - Objective: To determine whether providing individualized predictions of health outcomes to men on active surveillance (AS) alleviates cancer-related anxiety and improves risk understanding. Materials and Methods: We consecutively recruited men from our large, institutional AS program before (n = 36) and after (n = 31) implementation of a risk prediction tool. Men in both groups were surveyed before and after their regular visits to assess their perceived cancer control, biopsy-specific anxiety, and burden from cancer-related information. We compared pre-/post-visit differences between men who were and were not shown the tool using two-sample t-tests. Satisfaction with and understanding of the predictions were elicited from men in the intervention period. Results: Men reported a relatively high level of cancer control at baseline. Men who were not shown the tool saw a 6.3 point increase (scaled from 0 to 100) in their perceived cancer control from before to after their visit whereas men who were shown the tool saw a 12.8 point increase, indicating a statistically significant difference between groups (p =.04). Biopsy-specific anxiety and burden from cancer information were not significantly different between groups. Men were satisfied with the tool and demonstrated moderate understanding. Conclusion: Providing individualized predictions to men on AS helps them better understand their cancer risk and should be considered at other clinical sites.
AB - Objective: To determine whether providing individualized predictions of health outcomes to men on active surveillance (AS) alleviates cancer-related anxiety and improves risk understanding. Materials and Methods: We consecutively recruited men from our large, institutional AS program before (n = 36) and after (n = 31) implementation of a risk prediction tool. Men in both groups were surveyed before and after their regular visits to assess their perceived cancer control, biopsy-specific anxiety, and burden from cancer-related information. We compared pre-/post-visit differences between men who were and were not shown the tool using two-sample t-tests. Satisfaction with and understanding of the predictions were elicited from men in the intervention period. Results: Men reported a relatively high level of cancer control at baseline. Men who were not shown the tool saw a 6.3 point increase (scaled from 0 to 100) in their perceived cancer control from before to after their visit whereas men who were shown the tool saw a 12.8 point increase, indicating a statistically significant difference between groups (p =.04). Biopsy-specific anxiety and burden from cancer information were not significantly different between groups. Men were satisfied with the tool and demonstrated moderate understanding. Conclusion: Providing individualized predictions to men on AS helps them better understand their cancer risk and should be considered at other clinical sites.
UR - http://www.scopus.com/inward/record.url?scp=85057811603&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85057811603&partnerID=8YFLogxK
U2 - 10.1016/j.urology.2018.08.021
DO - 10.1016/j.urology.2018.08.021
M3 - Article
C2 - 30171924
AN - SCOPUS:85057811603
SN - 0090-4295
VL - 121
SP - 118
EP - 124
JO - Urology
JF - Urology
ER -